These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 33190372)

  • 1. Evaluation of the potential interference of camouflage on the treatment of vitiligo: An observer-blinded self-controlled study.
    Li M; Wang F; Ding X; Xu Q; Du J
    Dermatol Ther; 2021 Jan; 34(1):e14545. PubMed ID: 33190372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of using oral methotrexate with phototherapy in the treatment of vitiligo in comparison with single phototherapy treatment: A double-blinded randomized controlled trial.
    Lajevardi V; Hosseini ZSS; Heidari S
    Photodermatol Photoimmunol Photomed; 2023 Nov; 39(6):657-662. PubMed ID: 37859524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repigmentation of acral vitiligo with tofacitinib combined with NB-UVB phototherapy: A case report.
    Sun XK; Xu AE
    Australas J Dermatol; 2023 Nov; 64(4):571-572. PubMed ID: 37635652
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of changes in color and size of vitiligo lesions during treatment with narrow band ultraviolet B.
    Tawfik NZ; Anbar MT; Atwa MA
    J Cosmet Dermatol; 2022 Aug; 21(8):3522-3529. PubMed ID: 34806278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature.
    Bishnoi A; Parsad D
    Photodermatol Photoimmunol Photomed; 2024 May; 40(3):e12968. PubMed ID: 38632705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Evaluation and Meta-Analysis of Randomized Controlled Trials of Fire Needle Combined Phototherapy for the Treatment of Vitiligo.
    Jiang H; Long X; Chen Y; Wang W
    Biomed Res Int; 2022; 2022():6984149. PubMed ID: 36164454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of fire needle therapy in treating non-segmental stable vitiligo: A randomized self-controlled clinical trial.
    Wang Y; Lin M; Huang F; Jia R; Xu W; He Q; Xiong Q; Hu Q; Diao Q; Liu Z
    J Cosmet Dermatol; 2024 Jun; ():. PubMed ID: 38894565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm.
    Marin Dit Bertoud Q; Bertold C; Ezzedine K; Pandya AG; Cherel M; Castillo Martinez A; Seguy MA; Abdallah M; Bae JM; Böhm M; Parsad D; Rosmarin D; Wolkerstorfer A; Bahadoran P; Blaise M; Dugourd PM; Philippo V; Delaval JM; Passeron T
    Br J Dermatol; 2023 Dec; 190(1):62-69. PubMed ID: 37615581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of natural health product treatment for vitiligo.
    Szczurko O; Boon HS
    BMC Dermatol; 2008 May; 8():2. PubMed ID: 18498646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pediatric Dermatologist's View of Pediatric Vitiligo.
    Weingarten M; Schwartz M; Heath C; Silverberg NB
    J Drugs Dermatol; 2024 Feb; 23(2):e77-e78. PubMed ID: 38306136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.
    Seneschal J; Speeckaert R; Taïeb A; Wolkerstorfer A; Passeron T; Pandya AG; Lim HW; Ezzedine K; Zhou Y; Xiang F; Thng S; Tanemura A; Suzuki T; Rosmarin D; Rodrigues M; Raboobee N; Pliszewski G; Parsad D; Oiso N; Monteiro P; Meurant JM; Maquignon N; Lui H; Le Poole C; Leone G; Lee AY; Lan E; Katayama I; Huggins R; Oh SH; Harris JE; Hamzavi IH; Gupta S; Grimes P; Goh BK; Ghia D; Esmat S; Eleftheriadou V; Böhm M; Benzekri L; Bekkenk M; Bae JM; Alomar A; Abdallah M; Picardo M; van Geel N
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2185-2195. PubMed ID: 37715487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the refractory vitiligo patient: current therapeutic strategies and future options.
    Wang X; Wu W; Chen J; Li C; Li S
    Front Immunol; 2023; 14():1294919. PubMed ID: 38239366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Combined Phototherapy and Melanocyte Transplantation on Indicators of Vitiligo Activity.
    Wang J; Luo H; Zhao X; Wang C; Yang L
    Dermatol Surg; 2024 Jul; ():. PubMed ID: 38984521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Consensus Recommendations on the Management of Vitiligo and the Role of Decapeptide in Vitiligo by the Delphi Method.
    Parsad D; Kandhari S; Dhurat R; Shah B; Majid I; Yadalla HK; Sakhiya J; Poojary S; Jagadish P; Banotkar PD; Babu R; Shivakumar YM; Bose SK; Jamadar S; Shah M; Tank B; Dhabhai R; Mittal SK; Bhushan P; Pandita A; Barve V
    Indian J Dermatol; 2023; 68(5):587. PubMed ID: 38099100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of CO
    Zhang L; Zhang J; Wang X; Zhao Z; Li Z; Miao G; Lv C
    Front Med (Lausanne); 2024; 11():1408409. PubMed ID: 39050532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal Biophysical Characteristics in Patients with Vitiligo and the Association with Thyroid Auto-immunity and Itch.
    Teh YL; Jamil A
    Indian J Dermatol; 2024; 69(2):201. PubMed ID: 38841249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
    van Geel N; Speeckaert R; Taïeb A; Ezzedine K; Lim HW; Pandya AG; Passeron T; Wolkerstorfer A; Abdallah M; Alomar A; Bae JM; Bekkenk M; Benzekri L; Böhm M; Eleftheriadou V; Esmat S; Ghia D; Goh BK; Grimes P; Gupta S; Hamzavi IH; Harris JE; Oh SH; Huggins R; Katayama I; Lan E; Lee AY; Leone G; Le Poole C; Lui H; Maquignon N; Meurant JM; Monteiro P; Oiso N; Parsad D; Pliszewski G; Raboobee N; Rodrigues M; Rosmarin D; Suzuki T; Tanemura A; Thng S; Xiang F; Zhou Y; Picardo M; Seneschal J
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2173-2184. PubMed ID: 37746876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of camouflage in vitiligo: A cross-sectional survey.
    Poondru S; Kundu RV
    J Cosmet Dermatol; 2023 Dec; 22(12):3524-3526. PubMed ID: 37352455
    [No Abstract]   [Full Text] [Related]  

  • 19. Upadacitinib and its role in the treatment of vitiligo: A new possible therapeutic perspective.
    Magdaleno-Tapial J; Hernández-Bel P; Esteve-Martínez A; Peñuelas-Leal R; Labrandero-Hoyos C; Sánchez-Carazo JL; Pérez-Ferriols A
    JAAD Case Rep; 2024 Apr; 46():57-58. PubMed ID: 38544872
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic efficacy of cell-based therapy in vitiligo: a research letter systematically reviewed using meta-analysis.
    Wang X; Ci H; Chen C; Chen S; Li H; Xie B; Li S; Li Y; Wang W
    Arch Dermatol Res; 2024 May; 316(5):198. PubMed ID: 38775972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.